TERN NASDAQ
Terns Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.7%
3M: +40.2%
YTD: +32.0%
1Y: +1647.5%
3Y: +310.5%
5Y: +161.1%
$52.95
Last traded 2026-05-15 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-96M
Net Income
-8.3% YoY
$-82M
Free Cash Flow
-17.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-14.2%
ROA-13.9%
ROIC753.9%
Valuation
P/E-51.4
P/B4.9
EV/EBITDA-25.0
Leverage
Debt/Equity0.00
Current Ratio62.41
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z121.84
Beneish M0.00